arrow
I

Ignaty Leshchiner

broad institute of mit and harvard
H指数:58
被引数:3.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Actionable genetic landscape and dynamics in circulating DNA from 12,827 patients with metastatic breast cancer

来自12,827例转移性乳腺癌患者循环DNA中可操作的遗传景观和动态

2026-09-220
OAAI
Tamoxifen induces PI3K activation in uterine cancer

他莫昔芬诱导子宫癌中PI3K的激活

2025-08-220
OAAI
A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma

精准肿瘤学中耐药性解码模型:胆管癌对FGFR抑制剂的获得性耐药

2024-12-011
OAAI
Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors

表现为多原发肿瘤的EGFR突变肺癌的发育镶嵌

2024-10-151
OAAI
Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations
2024-09-050
PRE
Allosteric PI3K-alpha inhibition overcomes on-target resistance to orthosteric inhibitors mediated by secondary PIK3CA mutations
2024-05-020
PRE
Strategies to overcome resistance to PI3Kalpha-selective inhibitors mediated by acquired alterations in the PI3K/AKT pathway
2024-04-050
PRE
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations

变构PI3Kα 抑制克服了继发性PIK3CA突变介导的对正构抑制剂的靶向抗性

2023-10-3114
OAAI
Tumor-specific immunity generated by a personalized neoantigen vaccination incorporating locally delivered ipilimumab in renal cell carcinoma.
2023-08-151
PRE
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
2023-05-0934
OAAI
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
2023-04-0656
OAAI
Immunoproteasome expression and checkpoint blockade response in advanced non-small cell lung cancer
2023-04-040
PRE
Mechanisms of genetic predisposition to multifocal lung cancer

多灶性肺癌的遗传易感性机制

2023-04-040
PRE
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

慢性淋巴细胞白血病向Richter综合征转化的进化史

2023-01-0940
OA
Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations
2022-02-151
PRE
Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma
2022-02-0118
OAAI